Cargando…
CD64-directed microtubule associated protein tau kills leukemic blasts ex vivo
Fc gamma receptor I (FcγRI, CD64) is a well-known target antigen for passive immunotherapy against acute myeloid leukemia and chronic myelomonocytic leukemia. We recently reported the preclinical immunotherapeutic potential of microtubule associated protein tau (MAP) against a variety of cancer type...
Autores principales: | Mladenov, Radoslav, Hristodorov, Dmitrij, Cremer, Christian, Gresch, Gerrit, Grieger, Elena, Schenke, Lea, Klose, Diana, Amoury, Manal, Woitok, Mira, Jost, Edgar, Brümmendorf, Tim H., Fendel, Rolf, Fischer, Rainer, Stein, Christoph, Thepen, Theo, Barth, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341865/ https://www.ncbi.nlm.nih.gov/pubmed/27564103 http://dx.doi.org/10.18632/oncotarget.11568 |
Ejemplares similares
-
Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases
por: Hristodorov, Dmitrij, et al.
Publicado: (2012) -
Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo
por: Hristodorov, D, et al.
Publicado: (2013) -
Human MAP Tau Based Targeted Cytolytic Fusion Proteins
por: Akinrinmade, Olusiji A., et al.
Publicado: (2017) -
Comparison of a mouse and a novel human scFv-SNAP-auristatin F drug conjugate with potent activity against EGFR-overexpressing human solid tumor cells
por: Woitok, Mira, et al.
Publicado: (2017) -
Lipid Mediators and Human Leukemic Blasts
por: Fiancette, Rémi, et al.
Publicado: (2011)